Teekay Corporation Reports Third Quarter 2017 Results
Nov 09, 2017 07:57 am UTC| Business
Highlights Reported consolidated GAAP net loss attributable to shareholders of Teekay of $12.6 million, or $0.15 per share, and consolidated adjusted net loss attributable to shareholders of Teekay(1) of $35.6 million,...
Active Biotech AB - Interim report January - September 2017
Nov 09, 2017 07:32 am UTC| Business
Third quarter in brief The company's application related to one of the patent families in the SILC project was granted patent in the US Preclinical data for a SILC substance was published in the...
TransGlobe Energy Corporation Announces Third Quarter 2017 Financial and Operating Results
Nov 09, 2017 07:01 am UTC| Business
CALGARY, Alberta, Nov. 09, 2017 -- TransGlobe Energy Corporation (TSX:TGL) (NASDAQ:TGA) (“TransGlobe” or the “Company”) is pleased to announce its financial and operating results for the three and nine months ended...
Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine
Nov 09, 2017 06:32 am UTC| Business
Study to help determine if MVA-BN RSV will be administered as a seasonal vaccine or if a single shot is effective for multiple seasons COPENHAGEN, Denmark, November 9, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC:...
DeNA Reports Second Quarter, Fiscal Year 2017 Financial Results
Nov 09, 2017 06:15 am UTC| Business
TOKYO, Nov. 09, 2017 -- DeNA Co., Ltd. (Tokyo:2432) today announced its IFRS and non-GAAP financial results for the quarter ended September 30, 2017. DeNA reported quarterly IFRS revenue of 36.9 billion yen, IFRS...
Gemalto launches world's first "all-in-one" IoT module delivering global LTE connectivity
Nov 09, 2017 06:05 am UTC| Business
New IoT module provides 12 band LTE coverage plus fall back to 3G and 2G in a single device ...
BOURBON: Financial information 3rd quarter and 9 months 2017
Nov 09, 2017 06:02 am UTC| Business
Paris, November 9, 2017 BOURBON Financial information 3rd quarter and 9 months 2017 Revenue for the 3rd quarter was down 12.7% (-9.2% at constant rates) compared to the 2nd quarter of 2017, still impacted...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update